Cancer Treatment News and Research

RSS

Study identifies phosphorylation-based biomarkers to guide cancer therapy

Precision medicine in cancer treatment uses genetic changes in the cancer cells to select the best therapies for individual patients.

28 Jul 2020

A new perspective on lung cancer

Perspectives in Lung Cancer is the first volume of Bentham Books new series, Frontiers in Lung Cancer. The new book, edited by Dr. Keyvan Moghissi et al., is a comprehensive compilation of basic and advanced topics on lung cancer pathology and treatment in a single volume.

28 Jul 2020

Novel label-free imaging method can differentiate active T cells from those off duty

T cells are the immune soldiers at the frontlines of the battle with infiltrating pathogens that seek to cause disease. A new study published in Nature Biomedical Engineering describes a novel label-free imaging technique that can differentiate active T cells from those off duty.

27 Jul 2020

Lego-inspired, tiny 3D-printed bricks designed to heal broken bones

Tiny, 3D-printed bricks have been designed to heal broken bones -- and could one day lead to lab-made organs for human transplant.

24 Jul 2020

Modulating immunometabolic processes to control lung infection

When drugs to kill microbes are ineffective, host-directed therapy uses the body's own immune system to deal with the infection.

23 Jul 2020

Combining two immunotherapies into a single treatment found to be more effective

Some of the most promising advances in cancer treatment have centered on immunotherapies that rev up a patient's immune system to attack cancer. But immunotherapies don't work in all patients, and researchers have been searching for ways to increase their effectiveness.

23 Jul 2020

Hollings Cancer Center researcher receives NCI grants for cancer immunotherapy studies

Hollings Cancer Center researcher Jessica Thaxton, Ph.D., is the recipient of two grants totaling $3.4 million from the National Cancer Institute for her work in cancer immunotherapy and cell stress, one of which is part of the Cancer Moonshot Initiative on immunometabolism.

23 Jul 2020

Researchers recreate pancreatic cancer tissue using 3D-cell culture technique

Pancreatic cancer is a life-threatening disease with very poor survival rates in patients, and--despite various efforts--its treatment remains challenging.

23 Jul 2020

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

In order for cancer to form in the human body, normal cells must acquire multiple mutations before they develop toward the disease.

23 Jul 2020

Ashion Analytics and Elevation Oncology form innovative cancer treatment partnership

Ashion Analytics LLC today announced a partnership with Elevation Oncology, a clinical stage biopharmaceutical company, focused on the matching of patients with tumors harboring an NRG1 gene fusion identified using Ashion's proprietary GEM ExTra test with CRESTONE, a registration-directed Phase 2 study sponsored by Elevation Oncology.

23 Jul 2020

Experts use genomic analysis tools to create personalized treatment for kidney cancer patients

Experts at City of Hope and the Translational Genomics Research Institute are using one of the world's most comprehensive genomic analysis tools to map out personalized treatment plans for metastatic kidney cancer patients.

22 Jul 2020

Immunotherapeutic intervention to reduce stress prevents tumor metastases

Tel Aviv University researchers have found that the short time period around tumor removal surgery (the weeks before and after surgery) is critical for the prevention of metastases development, which develop when the body is under stress.

22 Jul 2020

Patients diagnosed with cancer are more likely to have severe COVID-19 infection

Cancer patients diagnosed more than 24 months ago are more likely to have a severe COVID-19 infection, research has found. Cancer patients of Asian ethnicity or who were receiving palliative treatment for cancer were also at a higher risk of death from COVID-19.

22 Jul 2020

Monash University researchers pave way for affordable immunotherapies

Researchers from Monash University’s Institute of Pharmaceutical Sciences are paving the way for accessible and affordable cancer treatment by using powerful nanoscale tools to overcome the high costs and long lead-times associated with one of the world’s newest forms of immunotherapy: CAR-T cell therapy.

22 Jul 2020

Researchers investigate the genetic and molecular basis of PD-L2 regulation

In immune-related disorders, therapy often involves identifying the molecules responsible for immune dysregulation and targeting them using drugs.

22 Jul 2020

Cancer diagnostic capacity should be ramped up to avoid unnecessary deaths, say researchers

Delays to cancer referral through reduced use of the urgent GP referral pathway during the coronavirus pandemic could result in more than a thousand additional deaths in England, a new study reports.

22 Jul 2020

Fasting-mimicking diet along with hormone therapy could help treat breast cancer

A USC-led team of scientists has found that a fasting-mimicking diet combined with hormone therapy has the potential to help treat breast cancer, according to newly published animal studies and small clinical trials in humans.

21 Jul 2020

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

The Josep Carreras Leukaemia Research Institute, a public centre pertaining to the Generalitat de Catalunya's (Government of Catalonia) CERCA network, has created the OneChain Immunotherapeutics spin-off, the aim of which is to develop new immuno-oncological therapeutic tools with various preclinical candidates, based on CAR-T technology for different tumors, such as cortical T-cell acute lymphoblastic leukemia (coT-ALL), a rare subtype of leukemia that mainly affects children, and which has a poor prognosis.

20 Jul 2020

Researchers develop new nano drug that kills triple-negative breast cancer cells

Researchers at the University of Arkansas have developed a new nano drug candidate that kills triple negative breast cancer cells.

20 Jul 2020

How to decide whether or not to start treatment for prostate cancer?

You have been diagnosed with prostate cancer and your doctor gives you the option of not being treated, but of remaining under observation: is there any objective way you can decide to be treated or not treated? What should you do?

19 Jul 2020

Cancer Treatment News and Research

Study identifies phosphorylation-based biomarkers to guide cancer therapy

A new perspective on lung cancer

Novel label-free imaging method can differentiate active T cells from those off duty

Lego-inspired, tiny 3D-printed bricks designed to heal broken bones

Modulating immunometabolic processes to control lung infection

Combining two immunotherapies into a single treatment found to be more effective

Hollings Cancer Center researcher receives NCI grants for cancer immunotherapy studies

Researchers recreate pancreatic cancer tissue using 3D-cell culture technique

Reactivation of divergent signaling pathways can be leveraged to enhance cancer treatment

Ashion Analytics and Elevation Oncology form innovative cancer treatment partnership

Experts use genomic analysis tools to create personalized treatment for kidney cancer patients

Immunotherapeutic intervention to reduce stress prevents tumor metastases

Patients diagnosed with cancer are more likely to have severe COVID-19 infection

Monash University researchers pave way for affordable immunotherapies

Researchers investigate the genetic and molecular basis of PD-L2 regulation

Cancer diagnostic capacity should be ramped up to avoid unnecessary deaths, say researchers

Fasting-mimicking diet along with hormone therapy could help treat breast cancer

Josep Carreras Institute's spin-off aims to develop new immuno-oncological therapeutic tools

Researchers develop new nano drug that kills triple-negative breast cancer cells

How to decide whether or not to start treatment for prostate cancer?

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News